china pharma is a pharmaceuticals company based out of haikou. china pharma representatives, don’t miss out on opportunities to build relationships with members on linkedin. claim your page, write a simple description, and share content to attract followers that can lead to new customers, brand fans, and future employees. go here to get started: http://linkd.in/1dupbvu
Company profile
Ticker
CPHI
Exchange
Website
CEO
Zhilin Li
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
KILKENNY ACQUISITION CORP, SOFTSTONE INC, SOFTSTONE INC /DE/, TS ELECTRONICS INC
SEC CIK
Corporate docs
IRS number
731564807
CPHI stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
1 Apr 24
8-K
Other Events
29 Mar 24
8-K
China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split
23 Feb 24
EFFECT
Notice of effectiveness
15 Feb 24
CORRESP
Correspondence with SEC
14 Feb 24
8-K
Entry into a Material Definitive Agreement
8 Feb 24
S-3/A
Shelf registration (amended)
6 Feb 24
CORRESP
Correspondence with SEC
6 Feb 24
UPLOAD
Letter from SEC
25 Jan 24
S-3
Shelf registration
12 Jan 24
Transcripts
CPHI
Earnings call transcript
2019 Q4
31 Mar 20
CPHI
Earnings call transcript
2019 Q2
15 Aug 19
CPHI
Earnings call transcript
2019 Q1
15 May 19
CPHI
Earnings call transcript
2018 Q4
29 Mar 19
CPHI
Earnings call transcript
2018 Q3
15 Nov 18
CPHI
Earnings call transcript
2018 Q2
15 Aug 18
CPHI
Earnings call transcript
2018 Q1
15 May 18
CPHI
Earnings call transcript
2017 Q4
3 Apr 18
CPHI
Earnings call transcript
2017 Q3
15 Nov 17
Latest ownership filings
SC 13G
Liu Tao (Chengdu)
26 Jan 24
3
Tao (Chengdu) Liu
26 Jan 24
SC 13G/A
Streeterville Capital LLC
12 Jan 24
4
Zhilin Li
19 Oct 23
SC 13G
Deng Ke
9 Mar 23
3
Ke Deng
9 Mar 23
SC 13G/A
Streeterville Capital LLC
5 Dec 22
SC 13G
Streeterville Capital LLC
27 Sep 22
4
Zhilin Li
13 Sep 21
4
Zhilin Li
8 Jan 21
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.37 mm | 1.37 mm | 1.37 mm | 1.37 mm | 1.37 mm | 1.37 mm |
Cash burn (monthly) | (no burn) | 59.70 k | 259.20 k | 259.23 k | (no burn) | 7.73 k |
Cash used (since last report) | n/a | 411.64 k | 1.79 mm | 1.79 mm | n/a | 53.30 k |
Cash remaining | n/a | 958.23 k | -417.30 k | -417.52 k | n/a | 1.32 mm |
Runway (months of cash) | n/a | 16.1 | -1.6 | -1.6 | n/a | 170.3 |
Institutional ownership, Q2 2023
35.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 6 |
Opened positions | 5 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 24.04 mm |
Total shares | 5.31 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Streeterville Capital | 5.16 mm | $0.00 |
Renaissance Technologies | 63.85 k | $22.00 k |
Millennium Management | 36.67 k | $12.51 mm |
VIRT Virtu Financial | 21.31 k | $7.00 k |
Two Sigma Securities | 19.21 k | $6.55 mm |
Bridgeway Capital Management | 14.50 k | $4.95 mm |
Proequities | 0.00 | $0.00 |
News
12 Health Care Stocks Moving In Wednesday's After-Market Session
24 Apr 24
12 Health Care Stocks Moving In Friday's After-Market Session
19 Apr 24
12 Health Care Stocks Moving In Friday's After-Market Session
1 Mar 24
12 Health Care Stocks Moving In Tuesday's After-Market Session
27 Feb 24
12 Health Care Stocks Moving In Friday's After-Market Session
23 Feb 24